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Abstract.  Tenascin, a  predominantly mesenchymal ex- 
tracellular matrix (ECM) glycoprotein has a  rather re- 
stricted tissue distribution, but until now factors that 
inhibit its expression have not been identified. 
Glucocorticoids are known to be beneficial for estab- 
lishment of myelopoiesis in long-term bone marrow 
cultures. Tenascin was found to be expressed in the 
bone marrow, and glucocorticoids were found to affect 
bone marrow tenascin expression.  Both tenascin 
mRNAs and the mRNA of another ECM protein, 
laminin B1  chain, were drastically downregulated by 
glucocorticoids during initiation of bone marrow cul- 
tures.  However, in already established long-term cul- 
tures glucocorticoids did not affect laminin B1  chain 
mRNA levels although tenascin mRNAs continued to 
be downregulated. Studies with a  stromal cell line 
(MC3T3-G2/PA6) and fibroblasts (3T3)  suggested that 
glucocorticoids act directly on the stromal cells that 
produce tenascin. In 3T3 cells this downregulation oc- 
curred within 12 h  of glucocorticoid-treatment, sug- 
gesting that glucocorticoids acted through cis regula- 
tory elements of the tenascin gene. We suggest that 
glucocorticoids in part regulate hematopoiesis by 
modifying the ECM. Furthermore, downregulation of 
tenascin expression by glucocorticoids may in part ex- 
plain the restricted tissue distribution of tenascin in 
other tissues. 
T  ENASCINS are large extracellular matrix (ECM) ~  gly- 
coproteins arranged as polymers of up to six chains. 
Each chain contains a series of EGF-like domains at 
the amino-terminal end followed by a series of fibronectin 
type HI domains, and a fibrinogen type domain at the car- 
boxy-terminal end (Spring et al.,  1989; Jones et al.,  1989; 
N6renberg et al., 1992). The first described tenascin was re- 
cently named tenascin-C (Bristow et al.,  1993),  but it will 
here be referred to as tenascin. It has received much attention 
because of  its expression in healing wounds and in the stroma 
close to epithelial cells during embryogenesis and carcino- 
genesis (Chiquet-Ehrismann et al., 1986; Ekblom and Auf- 
derheide,  1989).  It is also found in the cerebellum, devel- 
oping cartilage, and some other tissues (Koukoulis et al., 
1991; Natali et al., 1991). However, its tissue distribution is 
more restricted than several other ECM proteins such as 
fibronectin and the major laminins. Transforming growth fac- 
tor ~  stimulates expression of many ECM components in- 
cluding tenascin (Pearson et al., 1988; Massagur, 1990) but 
the limited expression of tenascin in vivo suggests mecha- 
nisms that downregulate tenascin expression in the body. In- 
deed, fibroblasts which in vivo produce very little tenascin 
rapidly begin to produce tenascin when cultured in vitro. 
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Yet, physiological inhibitors of tenascin expression have not 
been identified. In experiments with cells treated with gluco- 
corticoids we noted that tenascin expression might be af- 
fected by the hormone. To learn more about regulation of 
tenascin synthesis, we therefore studied tenascin expression 
in long-term bone marrow cultures, an organ culture system 
where glucocorticoids are required for differentiation. 
Long term bone marrow cultures, which consist of a het- 
erogenous population of stromal and hematopoietic cells can 
be used as in vitro models for hematopoiesis (Dexter et al., 
1977;  Whitlock and Witte,  1982;  Kincade et al.,  1989). 
Glucocorticoids have been suggested to influence the stromal 
layer (Greenberger, 1978; Suda and Dexter, 1981; Eliason, 
1984), but it is not clear at the molecular level how glucocor- 
ticoids  act  in  these  cultures.  Glucocorticoids have  been 
reported to downregulate collagen expression in adult but 
not embryonic fibroblasts (Russell et al.,  1989) and to up- 
regulate fibronectin expression (Oliver et al.,  1983).  How- 
ever, the effect of glucocorticoids on the ECM of bone mar- 
row cells has not been studied in any detail. Glucocorticoids 
were recently shown to cause subtle changes in the sugar 
composition of bone marrow stromal proteoglycans (Sicz- 
kowski et al., 1992) but other more profound effects may oc- 
cur.  We here report that bone marrow contains both major 
splice variants of tenascin and that they continue to be ex- 
pressed  in  long-term bone  marrow  cultures.  Laminin B 
chains and nidogen were also found in the native bone mar- 
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can be used to study physiologically relevant cell-matrix in- 
teractions.  We  found  that  glucocorticoids  downregulated 
tenascin and laminin B1 chain expression during initiation of 
long-term bone marrow cultures. Interestingly, only tenascin 
expression was affected in established long-term bone mar- 
row cultures. 
There is previous evidence that the ECM could participate 
in the regulation of hematopoiesis.  Stromal calls as well as 
stem cells and lymphoid and myeloid progenitors  express 
several  known  cell  adhesion  molecules  (Hemler,  1988; 
Miyake et al., 1990; Teixid6 et al., 1992). Stromal ceils also 
synthesize and deposit a large number of known ECM com- 
ponents (Bentley and Foidart,  1980; Del Rosso et al.,  1981; 
Zuckerman et al.,  1985; Long and Dixit,  1990). Inhibitors 
of collagen deposition decrease cell proliferation  (Zucker- 
man et al.,  1985), while stimulation of glycosaminoglycan 
synthesis enhances hematopoiesis (Spooncer et al.,  1983). 
Of the  defined  components,  fibronectin,  collagen  I,  and 
thrombospondin have been shown to be adhesive for hemato- 
poietic ceils (Lanotte et al.,  1981;  Giancotti et al.,  1986; 
Weinstein et al.,  1989; VerfaiUie et al.,  1991), but the adhe- 
sion capacity of the cells depends on the lineage and stage 
of differentiation (Coulombel et al.,  1988; Koenigsmann et 
al., 1992; Long and Dixit, 1990; Williams et al., 1991). The 
binding  to fibronectin induces  differentiation  of immuno- 
globulin-secreting cells of the marrow (Roldfin et al.,  1992) 
and murine erythroleukemia cells (Patel and Lodish, 1987), 
and stimulates proliferation of erythroid cells (Weinstein et 
al.,  1989). Granulocyte progenitors also adhere to fibronec- 
tin, although to a lesser degree than erythroid calls (Tsai et 
al.,  1987;  Koenigsmann et al.,  1992; Rold(m et al.,  1992). 
Tenascin has been shown to modulate the binding of mono- 
cytes and other cells to fibronectin (Chiquet-Ehrismann  et 
al.,  1988,  1991;  Erickson  and Bourdon,  1989).  It is thus 
likely that the modification of the ECM composition by glu- 
cocorticoid hormones is important  for hematopoiesis. 
Materials and Methods 
Animals and Cells 
C57 black mice (6-14 wk old) were used for long-term bone marrow cul- 
tures.  For immunofluorescence and immunoblotting bone marrow from 
DBA/1, NMRI, or C57bl  x  National Medical Research Institute (NMRI) 
mice were used. 
Long-Term Bone Marrow Cultures 
Bone marrow cultures of myeloid cells were initiated and maintained ac- 
cording to Dexter et ai.  (1977).  1.9-6  x  106 cells/ml from femurs were 
cultured in Nuncion tissue culture flasks. The culture medium consisted of 
Fischer's medium (GIBCO BRL, Gaithersburg, MD), 20%  horse serum 
(GIBCO BRL) and 10  -6 M hydrocortisone sodium succinate (Solu-Cortef, 
Upjohn, Kalamazoo, MI). After 1 wk of culture two thirds of the initial vol- 
ume of fresh medium was added. Half of  the medium and non-adherent  cells 
were thereafter replaced by fresh medium weekly. The cultures were in- 
cubated in 5 % COz at 33°C. In some cultures hydrocortisone was omitted 
or replaced by 10  -5 or 10  -7 M dexamethasone (Sigma Chemical Co., St. 
Louis, MO) at onset of the cultures or 3 wk after culture in the presence 
of hydrocortisone. The MC3T3-G2/PA6 preadipocyte cells (Kodama et al., 
1982) and 3T3 or 3T3-L1  fibroblast cells (Green and Meuth, 1974)  were 
grown in DME (GIBCO BRL), 10%  FCS at 37°C in 5% CO2.  For mor- 
phological analyses, cytocentrifuge preparations of non-adherent and tryp- 
sin-treated adherent cells were stained with May-Griinwaid-Giemsa. 
Antisera and Antibodies 
Tenascin was detected in immunoblots and immunofluorescence with a rat 
monoclonal IgGl antibody MTn 12 reacting with both major mouse tenas- 
cin polypeptides of 260 and 210 kD. For immunoprecipitations, a mixture 
of the mAbs MTn 12 and MTn  15  (IgG 2a) was used. The mAbs were 
purified by Bakerbond Abx ion exchange chromatography using fast protein 
liquid chromatography (FPLC)  as described (Aufderbeide and Ekblom, 
1988).  Laminin  was  demcted  with  a  rabbit  antiserum  against  mouse 
Engelbreth-Holm-Swarm (EHS) tumor. This antiserum reacts with A, B1, 
and B2 chains of  laminin (Klein et ai., 1988, 1990). The A chain of laminin 
was detected with mAb 201 as a purified IgG (Soroidn et al.,  1992).  An 
affinity-purified rabbit antiserum was used to detect nidogen (Paulsson et 
ai., 1987; Mann et ai., 1988). S-chain oflaminin was detected with rat mAb 
D5 kindly provided by Dr. J. Sanes (Washington University, St. Louis, Mis- 
souri). Fibronectin was detected with a polyclonal antiserum specific for 
mouse fibronectin (a gift from Dr. K. Rubin, Biomedical Center, Uppsala 
University, Uppsaia, Sweden). Fluorescein anti-rat and rhodamine con- 
jugated anti-rabbit antisera were from Dianova GmbH (Hamburg, Ger- 
many) and Dako Corp. (Carpinteria, CA). The biotinylated anti-rabbit and 
anti-rat antibodies and streptavidin-fluoreseein were from Amersham In- 
ternationai (Amersham, UK). 
lmmunohlstochemical Analysis 
Femurs from adult mice were frozen in liquid nitrogen, and the bone mar- 
row was then dissected  on dry ice under a dissecting microscope. The mate- 
riai was overlaid on dry ice with Tissue Tek (Miles, Naperville, IL) and im- 
mediately thereafter frozen in liquid nitrogen. From newborn mice the 
femurs were frozen in Tissue Tek together with the surrounding tissues. 
Cryostat sections (5-7/~m) were fixed with -20"C methanol for 5 min, 
washed with PBS and incubated with 5 % horse serum in PBS for 5 rain. 
Monoclonal anti-tenascin antibody was used at 50 ttg/rnl, monoclonal anti- 
laminin A antibody at 8/~g/ml, anti-laminin antiserum was used diluted 
1:1,000, monoclonai anti-laminin s-chain antibody 1:100, and anti-nidogen 
antiserum 1:100.  The secondary antibodies, fluorescein and rhodamine- 
conjugated anti-rat and anti-rabbit antisexa were used diluted 1:200. In con- 
trol stainings the primary antibody was omitted or nonimmune rabbit serum 
(dilution 1:1,000) was used instead of the primary antiserum. Immnnotluo- 
resccut stainings of long-term cultures grown on eoverslips were performed 
after fixation with methanol. Immunolocalization studies were performed 
with cultures initiated and maintained in the presence of hydrocortisone. 
Immunoblotting 
For immunoblotting the adult mouse bone marrow was isolated frozen after 
immersion of the femur in liquid nitrogen. From bone marrow cultures ad- 
herent cells were scraped off in the buffer. Tissues were homogenized by 
sonication in TBS, pH 7.4, containing 10 mM EDTA and protease inhibitors 
(Pauisson et ai., 1987).  After sonication the homngenates were kept on ice 
for 1 h, centrifuged, and the protein content of the supernatants was deter- 
mined with the Bio-Rad Laboratories (Richmond, CA) protein assay.  As 
controls, extract from EHS tumor (Klein et al.,  1988)  was used. Before 
electrophoresis the samples were boiled for 5 rain in Laemmii buffer con- 
taining WIT. Proteins were separated on a 4-15% Mini-Protean 1I gradient 
gel (Bio-Rad Laboratories). Rainbow" molecular weight markers (Amer- 
sham) were run in parallel to estimate the apparent molecular weights. As 
blocking solution 3% BSA (globulin free; Sigma Chemical Co.) and 0.05% 
Tween-20 was  used.  Purified anti-tenascin antibodies were used at  50 
~g/ml, anti-laminin antiserum at dilutions 1:1,000-300,  and anti-nidogen 
antiserum at 1:75. The biotinylated anti-rabbit or anti-rat antibodies were 
used at 1:200 dilution and streptavidin-biotinylated HRP complex (Amer- 
sham) at  1:400  dilution in PBS. The color reaction was performed with 
4-chloro-l-naphthol and H2Oz. 
Immunoprecipitation 
Monolayers of MC33T3-G2/PA6 fibroblasts, confluent to '~75 %, were cul- 
tured either untreated or treated with 10  -5 M and 10  -7 M dexamethasone 
for 48 h. Cells were then washed with PBS, and incubated with methionine- 
and cysteine-free labeling media containing [35S]methionine-cysteine  for 
24 h in the presence or absence of the same concentrations of dexametha- 
sone. Control plates received ethanol instead of ethanol+dexamethasone 
during the labeling period. After labeling the media were removed and 
The Journal of Cell Biology,  Volume 123, 1993  1038 Figure L  Tenascin, laminin, and nidogen in the bone marrow of newborn mouse. Immunofluorescence staining with anti-tenascin antibody 
mTn 12 shows tenascin as thin fibers among the bone marrow cells (A). Double staining of the same section with the anti-laminin antiserum 
detecting both A  and B chains (B) shows bright staining in the muscle layer of the arteriole (closed arrow) and in the wall of the sinusoid 
(open arrows).  In addition, there are thin fibers with laminin around cells within the bone marrow.  Staining with anti-nidogen antiserum 
shows reaction in the muscle layer of the arteriole and in the wall of the sinusoid (C), whereas staining of the same section with monoclonal 
anti-laminin A  chain shows no staining above background (D).  Bar,  100/~m. 
1 mM PMSF and 70% ammonium sulfate were added.  After 3 h at 4°C, 
the  media  were  centrifuged  at  3,000  rpm  for  20  min.  Pellets  were 
resuspended  in  0.5  ml  TBS  and  dialyzed  against TBS.  Samples  were 
precleared  by  addition of 25  /~g/ml normal  rabbit IgG,  25  /~g/ml rat 
anti-mouse IgG, protein A-Sepharose and protein G-Sepharose (Pharma- 
cia, Uppsala, Sweden) by mixing for 2 h at 40C. Precleared material was 
aliquoted into samples containing equal amounts of epm. Samples were in- 
cubated for 2 h at 4°C with 40 #g/ml of MTn 12 and MTn 15, or with 13 
#g/ml rabbit anti-rat fibronectin, or 30/~g/ml rat anti-mouse IgG. Rabbit 
anti-rat (25/~g/ml) and 30 #1 protein A-Sepharose was added to bind MTn 
12 (IgG1) and rat anti-mouse IgG-containing samples.  Protein G-Sepha- 
rose (30/xl) was added to bind MTn 15 (IgG 2a)-containing samples.  Pro- 
tein A-Sepharose was added to rabbit anti-rat fibronectin-containing  sam- 
pies.  Incubation with protein beads was for  1 h at 40C. After spinning, 
pellets were washed 3 times with RIPA (1% Triton X-100, 0.5% deoxyeho- 
late, 0.1% SDS in TBS containing  0.6 mM MgSO4 and 1 mm CaC12), twice 
with 0.5% Triton X-100, 0.5 M NaC1, and once with 0.25%  Triton 3[-100, 
0.25 M NaC1. Pellets were treated with sample denaturing buffer, TBS and 
DTT and boiled for 5 rain. 50 #1 of sample were loaded per well on 5 % 
PAGE-SDS gels. Gels were fixed, treated with fluorography enhance, dried 
and exposed  on x-ray film. 
Northern Blotting 
Total RNA was isolated from 3"1"3  cells as described by Auffray and Rougeon 
(1980). RNA from other coils and tissues was isolated by acid gnanidinium 
thiocyanate-phenol-chloroform  extraction  (Chomczynski  and  Saeehi, 
1987).  RNA was eleetrophoretically  separated, blotted onto Zeta-Probe 
membrane (Bio-Rad Laboratories), UV cross-linked and probed in Church 
buffer  (Church and Gilbert,  1984)  at 65"C.  The following  oligolabeled 
eDNA probes were used:  (a) p-5'6 corresponding to the 5' region of mouse 
tenasein; (b) M20/I corresponding to the middle region of mouse tenascin 
(Weller  et al.,  1991); (c) the Sph-Hind/lI fragment of eDNA clone for 
mouse laminin BI chain (Oberbiumer, 1986);  (d) a clone for mouse ~l- 
integrin subunit detecting  two polyadenylation  variants of the mRNA; (e) 
a clone for mouse #-actin (Minty et al.,  1983); (f) and a clone for human 
G3PDH (Clonteeh, Palo Alto, CA). Upon hybridization the blot with 3T3 
RNA was washed twice for 30 rain at 650C in a solution containing 0.1  × 
SSC and 1% SDS.  The other blots were washed twice with 0.02 M Naz 
HPO4, 5% SDS and twice with 0.02 M Na2HPO4,  1% SDS for 60 min at 
65"C (Sambrook et al., 1989). The blots were exposed at -70"C on a Ko- 
dak X-OMAT  film (Eastman Kodak Co.,  Rochester,  NY) for 1-14 days. 
Quantitation of signal intensities were performed by densitometric scanning 
Ekblom et al. Glucocorticoids Downregulate Tenascin Expression  1039 Figure 2. Laminin and tenascin in the adult mouse bone marrow. Sections of the central bone marrow (A and B) and more peripheral 
areas (C and D) were double stained for tenascin (A and C), and laminin A and B chains (B and D). Open arrows show sinusoidal walls, 
and closed arrows show the blood vessels. Bar, 50/~m. 
of Northern blots using an LKB laser densitometer. Values were normalized 
to G3PDH signal intensities. 
Results 
Localization of  Laminin and Tenascin in the Bone 
Marrow and in Long-Term Bone Marrow Cultures 
In bone marrow of newborn mice tenascin was expressed as 
thin fibers in the intersinusoidal spaces among the bone mar- 
row cells. Tenascin was also expressed in the wails of arteries 
but not in the sinusoidal linings (Fig.  1 A). The distribution 
of laminin was much more widespread then tenascin. Lami- 
nin was expressed in the walls of the arteries and veins and 
also in the sinusoidal walls (Fig. 1 B). Thin strands were also 
seen in extravascular areas close to bone marrow cells, as 
reported previously for rat (Hamilton and Campbell, 1991). 
The staining pattern for nidogen was identical to the laminin 
B chain polypeptides in newborn (Fig.  1 C) and adult (not 
shown)  mouse bone marrow.  A  monoclonal antibody 201 
against laminin A  chain did  not show any reaction above 
background (Fig.  1 D). By immunoblotting or immunofluo- 
rescence we failed to detect the s-chain of laminin in mouse 
or rat bone marrow (data not shown). 
In the adult bone marrow staining for tenascin remained 
positive, but was weaker in the intersinusoidal spaces than 
in newborn bone marrow. Tenascin expression was particu- 
larly weak in the central area of the adult bone marrow, also 
in the arteriolar walls (Fig. 2 A), but more expression was 
seen in the subcortical areas (Fig. 2  C). Laminin chains re- 
mained well expressed in the adult bone marrow both in the 
blood vessel wails (Fig. 2 B) and in the sinusoidal walls (Fig. 
2, B and D). Tenascin and laminin continued to be well ex- 
pressed in the long-term in vitro cultures of adult bone mar- 
row. In the cultures tenascin was seen as fibers between the 
stromal cells (Fig.  3 A),  whereas laminin was seen as in- 
tracytoplasmic perinuclear deposits in  some large stromal 
cells, but also in the extracellular matrix (Fig. 3 B). In the 
ECM of the bone marrow cultures no extensive codistribu- 
tion of tenascin and laminin was noted. 
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the bone marrow, in cultured marrow and in cultured cells. Immu- 
noblotting  was performed with monoclonal anti-tenascin  antibody 
MTn 12 (lanes 1-3) or with second antibody alone (lanes 4 and 5), 
polyclonal anti-laminin  (lanes  6--8) or nonimmune rabbit serum 
(lanes 9 and 10), and anti-nidogen antiserum (lanes//and 12) or 
nonimmune rabbit serum (lanes  13 and 14). Lysates blotted were 
from cell line MC3T3-G2/PA6  (lane 1), adherent cells from long- 
term bone marrow cultures  (lanes  2, 4,  7,  9,  H,  and 13), adult 
mouse bone marrow (lanes 3, 5, 8, 10, 12, and 14), and EHS-extract 
(lane  6).  The  second antibodies  used  alone  frequently  reacted 
strongly with bands of ~130 kD in the extracts  from the cultured 
bone marrow (lane 4), but not from the native bone marrow (lane 
5) which explains  the extra bands in lanes 1 and 2. Two tenascin 
polypeptides (arrows) are visible in the cell line MC3T3-G2/PA6 
(lane  1),  in bone marrow cultures  (lane 2),  and in bone marrow 
(lane 3). Although the anti-laminin  antiserum reacts both with the 
400-kD laminln A chain and the 200-kD B chains (arrows) in the 
EHS extract (lane 6), only B chains were detected with the same 
antiserum in extracts  from bone marrow cultures (lane  7) or adult 
mouse bone ~  (lane 8). The anti-nidogen  antiserum detects 
a polypeptide of 150 kD (arrow) in the marrow cultures (lane//) 
and in the bone marrow (lane 12). In control immunoblots of bone 
marrow (lanes 5 and 10) and bone marrow cultures (lanes 4, 9, and 
12) with the  secondary anti-rat  (lanes  4  and 5)  and  anti-rabbit 
(lanes  9,  10, 13 and 14) antiserum the primary antibodies  were 
omitted.  Right margin indicates  Mr X  10  -3. Gels were run under 
reducing conditions.  Tn, tenascin;  A, laminin A chain; B, laminln 
B chains,  and N, nldogen. 
Figure 3. Localization of tenascin and laminin in the adherent layer 
of  long-term bone marrow culture.  Cells grown on a coverslip were 
stained with anti-tenascin  antibody MTnl 2 (A). Tenascin is seen ex- 
tracellularly arranged in large fibrils, lmmunofluorescence staining 
with the anti-laminin  antiserum shows some extracellular  deposi- 
tion of laminin,  but laminin  is  predominantly  found within  the 
stromal  cells  perinuclearly (B). Bar,  20 #m. 
Chain Composition of Tenascin and Laminin in the 
Bone Marrow 
Immunoblotting revealed the presence of both the 260- and 
210-kD tenascin polypeptides in cultures of the established 
preadipocyte-stroma cell line (Fig.  4,  lane/),  in the long- 
term cultures (Fig. 4, lane 2) and in the native bone marrow 
(Fig.  4,  lane  3).  There  was  a  slight  predominance  of the 
larger polypeptide in all  these samples.  Laminin in tissues 
exists as several different isoforms which differ by the poly- 
peptide  chain composition.  Isoforms devoid of the laminin 
A-chain polypeptide are particularly  common both in em- 
bryonic and adult tissues,  but so far there has not been any 
information about the subunit composition of bone marrow 
laminin.  With an A-chain-specific mAb we failed to detect 
the A  chain in immunofluorescence (see Fig.  1).  In agree- 
ment with these findings, we detected only 200-kD B-chain 
polypeptides in the native bone marrow (Fig. 4, lane 8) and 
in the cultured stromal cells (Fig. 4, lane 7) with an antise- 
rum that detects both A  and B  chains of laminin  from the 
EHS tumor (Fig. 4, lane 6). Immunoblotting for nidogen, a 
160-kD  protein  associated  with  laminin  (Timpl,  1989), 
showed a  160-kD band from the culture cells and the native 
bone  marrow.  Another  weak  100-kD  nidogen  band  was 
seen in bone marrow lysates, probably a degradation product 
of nidogen due to endogenous or exogenous proteases (Fig. 
4, lanes//and 12). The results and the immunofluorescence 
strongly suggest that the cultured stromal bone marrow cells 
continue to produce the same isoforms of laminin and tenas- 
cin as the native adult bone marrow. 
Downregulation of Tenascin Expression in Bone 
Marrow Cultures by Glucocorticoids 
We first studied whether glucocorticoids affected tenascin or 
laminin expression in bone marrow cultures during the initial 
formation of the  stromal  cell  layer.  When glucocorticoids 
were present from the onset of the bone marrow cultures,  a 
nearly confluent adherent cell layer, a  stroma,  formed after 
3 wk. In contrast, the stroma was less well developed when 
cultures were initiated without glucocorticoid supplementa- 
tion,  as reported  (Suda and Dexter,  1981),  A  transient  in- 
crease in the number of nonadherent cells occurred on the 
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downregulate  tenascin  and 
laminin B1  and mRNAs dur- 
ing  initiation  of  long-term 
bone marrow cultures. North- 
ern  blotting  of tenasein  and 
laminin  B1  mRNA  in  long 
term  bone  marrow  cultures 
(lanes 1-4)  and in a  stromal 
cell  line  MC3T3-G2/PA6 
(lanes  6--8).  Lanes 1-4 were 
loaded with 7/tg, lane 5 with 
10/~g, and lanes 6--8 with 12 
t~g of total RNA, and North- 
ern  blotting  was  performed 
with  oligolabelled  tenasein 
eDNA  TN-20/I  (Tn) and  a 
eDNA clone for mouse lami- 
nin  B1.  Loading  in  each  gel 
was monitored by probing with 
a eDNA detecting G3PDH mRNA. Total RNA was isolated from 
the adherent cell layer of  bone marrow cultures initiated in the pres- 
ence of 10  -6 M  hydrocortisone (lane 1),  10  -5 M  dexamethasone 
(lane 2),  10  -7 dexamethasone (lane 3), or absence of glucocorti- 
coids (lane 4), and from the non-adherent cells grown in the pres- 
ence of 10-6 M  hydrocortisone (lane 5).  Similar Northern blots 
were performed with the MC3T3-G2/PA6 cell line grown in the 
presence of 10  -7 M  dexamethasone (lane 6),  10  -5 M  dexametha- 
sone (lane  7), or without glucocorticoids (lane 8).  Tn, tenascin; 
/amB/, laminin B1 chain; and G3PDH, glycerol 3-phosphate dehy- 
drogenase. 
second week in cultures  lacking glucocorticoids.  This cor- 
related  with  tenascin  mRNA  expression;  glucocorticoids 
drastically  diminished  the  steady  state  levels  of tenascin 
mRNA in the adherent layer. Laminin B1 mRNA expression 
was  also  diminished  to  the  same  degree  (Fig.  5).  Non- 
adherent  cells  from the  cultures  grown  in  the presence  of 
hydrocortisone  did  not  express  any  detectable  tenascin 
mRNA  or  laminin  B1  (Fig.  5).  Densitometric  analysis  of 
RNA  signal  intensity  suggested  that  glucocorticoids  de- 
creased expression of tenasein and laminin mRNA in the ad- 
herent layer by ,~70-90%  (Fig.  6  B). 
We  next  studied  whether  omission  of  glucocorticoids 
could affect enascin or laminin expression once the adherent 
stromal cell layer had been established.  Cultures  were first 
grown for 3  wk in the presence of 10  -6 M  hydrocortisone, 
and were then shifted to different culture conditions contain- 
ing  either  no  steroids,  10  -6  M  hydrocortisone  or  10  -~  or 
10  -7  M  dexamethasone.  During  the  culture  period  there 
were  no obvious qualitative  or quantitative  morphological 
differences  between  the  cultures  in  the  nonadherent  cells. 
Omission of glucocorticoids led to increased levels of tenas- 
cin  mRNA,  whereas  they  remained  low  in  cultures  sup- 
plemented  with  hydrocortisone  or dexarnethasone.  In con- 
trast, laminin B1 mRNA steady-state levels were not in any 
way affected by differences in glucocorticoid  concentration 
in these cultures  (Fig.  6  C). 
Downregulation of Tenascin Expression by 
Glucocorticoids in Established Cell Lines 
To study whether the inhibition of tenascin expression by the 
glucocorticoids was due to a direct effect on stromal cells or 
mediated  through  another  cell  type,  two  established  cell 
lines were used.  In both the preadipocyte cell line MC3T3- 
G2/PA6 (Fig.  5) and in 3T3 cells (Fig.  6 A) glucocorticoids 
drastically downregulated  the steady-state levels of tenascin 
mRNA. In a time course study performed with 3"1"3 cells the 
response reached a maximum at the mRNA level (~90% in- 
hibition)  already  within  12  h  of glucocorticoid  treatment, 
and persisted during the whole 6-(t culture period (Fig.  7). 
In  contrast,  no  downregulation  of  the  expression  of/51- 
integrin  mRNA could  be seen,  either by a  1-wk treatment 
with  100 nM dexamethasone or by a  short treatment with a 
high dose of 10/zM for 24 h  (Fig.  7).  Immunoprecipitation 
of metabolically labeled cells confirmed that tenascin poly- 
peptide synthesis was reduced by dexamethasone treatment. 
In fibroblasts (MC3T3-G2/PAt)  analyzed on the second day 
of culture, dexamethasone strongly reduced synthesis of the 
260-kD  tenascin  polypeptide variant,  but only slightly  re- 
duced the synthesis of the 210-kD polypeptide (Fig.  8).  No 
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Figure 6.  Differentiation-depen- 
dent  regulation  of the  ECM  by 
glucocorticoids.  Densitometric 
analysis of Northern blotting for 
tenasein  ([])  and  larninin  (D) 
were normalized to G3PDH sig- 
nal  intensities.  MC3T3-G2/PA6 
cells were cultured for one week 
in  the  presence  or  absence  of 
dexamethasone (DXM) (A). Bone 
marrow  stromal cells  (stroma) 
were initiated in the presence of 
dexamethasone,  hydrocortisone 
(HC)  or  without hormones  and 
RNA levels for tenascin and lami- 
nin B1 were analyzed (B). In an- 
other set of experiments the stroma was first allowed to develop well in the presence of hydrocortisone for 3 wk (stroma/HC). Cultures 
were then exposed to different concentrations of glucocortieoids or cultured without hormones, and analyzed for tenasein and laminin 
B1  expression after 1 wk (C).  Numbers are percent of signal intensities of cultures grown without glucoeorticoids (control). 
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the  effect of glucocorticoids 
on steady-state levels of  tenas- 
tin  mRNA.  3T3  cells  were 
grown  without  glucocorti- 
coids (lane 1), in the presence 
of 100 nM dexamethasone for 
4  h  (lane 3),  12 h  (lane 4), 
24 h  (lane  5),  4  d  (lane  6), 
and  6  d  (lane  7),  or  in  the 
presence of 10 #M dexameth- 
asone  for 24  h  (lane  8).  A 
control blot of cells grown for 
24 h in the presence of ethanol 
only, used to solubilize dexa- 
methasone  is  provided  to 
show  that  ethanol  does  not 
influence tenascin  expression 
(lane 2).  10 #g of total RNA 
from each time point was probed with oligolabelled cDNA p5'-6 
detecting tenascin mRNA and cDNA detecting the two polyadenyl- 
ation variants  of the mouse/3Lintegrin subunit.  Blotting with a 
cDNA for ~ actin shows that an equal amount of RNA was loaded. 
At higher exposure levels not shown here, some expression oftenas- 
cin was seen in all lanes.  Tn, tenascin; Int~,  integrin/~1  subunit. 
Discussion 
Glucocorticoids are known to be important for myelopoiesis 
in vitro but the molecular mechanisms of the effect are not 
clear (Dexter and Spooncer,  1987;  Dorshkind,  1990).  Our 
current study raises the possibility that glucocorticoids affect 
hematopoiesis by modifying the ECM.  During initiation of 
long-term bone marrow cultures glucocorticoids drastically 
downregulated the  steady-state levels of both tenascin and 
laminin B1 chain mRNA, by >80 %. Interestingly, no such 
effect could be seen on laminin mRNA once the bone mar- 
row stroma cell layer had formed whereas tenascin mRNA 
levels continued to be downregulated.  In bone marrow cul- 
tures many interacting cell types are present, but our findings 
on 3T3  fibroblastic and MC3T3-G2/PA6 preadipocyte cell 
lines suggest that glucocorticoids act directly on the stromal 
cells that produce tenascin. 
By immunohistology tenascin and laminin were localized 
in  discrete locations of the bone marrow.  In the  newborn 
mouse bone marrow tenascin was widely expressed in the in- 
tersinusoidal spaces. In adult bone marrow tenascin expres- 
sion in the intersinusoidal spaces was weaker and was seen 
predominantly in the subcortical areas. Laminin was more 
widely expressed within the bone marrow stroma. Neither 
laminin A chain nor s-chain but only chains reacting with anti- 
bodies against B1 and B2 chains were found in the marrow. 
Hence bone marrow laminin resembles mesenchymal rather 
than epithelial laminin (Klein et al.,  1990;  Ekblom et al., 
1990).  Nevertheless,  the  laminin binding  protein  nidogen 
was expressed in the bone marrow with a similar distribution 
as laminin,  suggesting that laminin A-chain polypeptide is 
not necessary for the laminin-nidogen assembly. Since bone 
marrow laminin lacks the A chain it should not bind to the 
laminin receptor integrin ot6/~l  (Deutzmann et al.,  1990). 
The  biological  role  of bone  marrow laminin  is  therefore 
unclear. However, it could be involved in a variety of adhe- 
sive events during hematopoiesis.  Anti-laminin antibodies 
Figure 8.  Reduction of tenas- 
cin  polypeptide  biosynthesis 
by  dexamethasone.  MC3T3- 
G2/PA6  ceils  were  cultured 
for 48  h  in  the  absence  of 
dexamethasone  (lanes  1  and 
4)  or  presence  of  10  -2  M 
(lanes 2  and 5) and  10  -7 M 
dexamethasone  (lanes  3  and 
6). After a 48-h culture in the 
indicated  concentrations  of dexamethasone cells  were metaboli- 
cally labelled  for 24 h  by l~SS]methionine-cysteine in the  same 
concentrations  of dexamethasone.  Immunoprecipitation  was per- 
formed with mAbs MTn  12 and MTn  15 against tenascin  (lanes 
1-3) and polyclonal antiserum against fibronectin (lanes 4-6). Im- 
munoprecipitated  proteins  were  analyzed  by  SDS-PAGE under 
reducing conditions.  Left margin indicates Mr  x  10  -3. 
have recently been shown to affect lymphocyte u:atticking 
(Kupiec-Weglinski and de Sousa, 1991),  and some leukemia 
cells have acquired increased ability to adhere to laminin 
(Verfaillie et al.,  1992). 
The role of tenascin is not well defined, but there is some 
evidence that it in vitro influences cell-matrix interactions. 
Tenascin has been suggested to act as an anti-adhesive agent 
(Chiquet-Ehrismann et al., 1986; Faissner and Kruse, 1990; 
Murphy-Ullrich et al.,  1991;  Lochter et al.,  1991).  It binds 
to  chondroitin  sulfate  proteoglycan  (Chiquet  and  Fam- 
brough, 1984; Hoffman et al.,  1988) and to fibronectin, and 
it  can  inhibit  adhesion  of cells  to  fibronectin  (Chiquet- 
Ehrismann et al.,  1988;  Riiegg et al.,  1989;  Lotz et al., 
1989). Our findings of tenascin expression in the bone mar- 
row stroma are in agreement with this hypothesis. Glucocor- 
ticoids downregulated tenascin mRNAs and led to decreased 
tenascin polypeptide content in the adherent stromal layers 
in long-term bone marrow cultures.  In glucocorticoid-defi- 
cient cultures increased tenascin polypeptide content was as- 
sociated with transient increase in non-adherent cells at 2 wk 
of culture and low levels of hematopoiesis thereafter.  This 
transient  increase  of nonadherent  cells  in  glucocorticoid- 
deficient cultures has been explained by possible toxicity of 
glucocorticoids  to  hematopoietic  progenitors  (Suda  and 
Dexter,  1981).  In the  light of our present studies  a  more 
likely alternative is that the glucocorticoids modulate cell- 
matrix interactions by influencing the biosynthesis of ECM 
components  such  as  tenascin.  In  glucocorticoid-deficient 
cultures the increased expression of tenascin could lead to 
decreased adhesion  of hematopoietic cells to other  ECM 
components and to the stroma. Analogously, it was previ- 
ously suggested that tenascin might be involved in the phys- 
iological cell shedding from intestinal villi (Probstmeier et 
al.,  1990). The availability of the in vitro model for hemato- 
poiesis, monoclonal antibodies that affect binding of cells to 
mouse tenascin (Husman et al.,  1992) and cDNA clones for 
several  species  that  allow  the  production  of recombinant 
tenascin  polypeptides  (Spring  et  al.,  1989;  Jones  et  al., 
1989; Siri et al.,  1991; Nies et al.,  1991;  Saga et al.,  1991; 
Weller et al.,  1991) should make it possible to experimen- 
tally study whether tenascin affects adhesion of hematopoi- 
etic cells. 
The mechanism of glucocorticoid regulation of tenascin 
synthesis is unclear. Glucocorticoid hormones act by form- 
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locate into the nucleus. In the nucleus glucocorticoids can 
regulate gene expression either directly by binding to gluco- 
corticoid responsive elements (Yang-Yen et al., 1990) or in- 
directly by interfering with other transcription factors (Dia- 
mond et al., 1990; Yang-Yen  et al., 1990; Jonat et al., 1990). 
In our experiments with 3T3  cells tenascin mRNA levels 
were reduced by glucocorticoids already between 4 and 12 h 
suggesting that the hormone-receptor complex acts directly 
on cis regulatory elements of the tenascin gene. To study the 
molecular basis of glucocorticoid regulation of tenascin ex- 
pression we are currently characterizing the promoter region 
of the mouse tenascin gene. 
Although glucocorticoids strongly decreased tenascin ex- 
pression, the changes in adhesive cell interactions caused by 
glucocorticoids in the bone marrow cultures could be due to 
reduced or altered expression of other adhesion proteins. 
Based on the current data it seems that glucocorticoids do 
not affect ECM synthesis as broadly as transforming growth 
factor fi (TGF-/~), which stimulates or influences synthesis 
of a very large number of ECM proteins, integrin receptors 
and enzymes degrading ECM (Massagut, 1990). Integrin ~1 
mRNA was not affected, suggesting that glucocorticoids do 
not cause a simultaneous downregulation of ECM receptors. 
However,  laminin B1 chain mRNA was downregulated by 
glucocorticoids in the bone marrow during the initiation of 
cultures.  Since a  number of ECM  proteins  or proteases 
degrading ECM are affected by glucocorticoids in other tis- 
sues (Russell et al.,  1989; Jonat et al.,  1990) at least some 
other ECM components may be affected in the bone marrow 
as well. 
The data showing that glucocorticoids strongly influence 
the expression of ECM components may turn out to be rele- 
vant for the understanding of clinical symptoms caused by 
excess of corticosteroids. These syndromes include skin at- 
rophy, impaired bone marrow differentiation, immunologi- 
cal deficiency leading to increased susceptibility to infec- 
tions, and a reduced wound healing capacity. There are no 
satisfactory explanations at the molecular level for the many 
side effects of glucocorticoids. It is tempting to speculate that 
at least some of them could be related to the downregulation 
of ECM components such as the tenascins and laminins. It 
will therefore be of interest to test whether the biosynthesis 
of other members of the tenascin and laminin families are 
affected by glucocorticoids. 
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